{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:54:46Z","timestamp":1791312886466,"version":"4.3.1"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T00:00:00Z","timestamp":1461801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00198-016-3515-9","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T17:03:12Z","timestamp":1461862992000},"page":"2147-2179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["The management of osteoporosis in children"],"prefix":"10.1007","volume":"27","author":[{"given":"L. M.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. N.","family":"Konji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,28]]},"reference":[{"key":"3515_CR1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/MED.0000000000000106","volume":"21","author":"LK Bachrach","year":"2014","unstructured":"Bachrach LK (2014) Diagnosis and treatment of pediatric osteoporosis. Curr Opin Endocrinol Diabetes Obes 21:454\u2013460","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"3515_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrrheum.2013.45","volume":"9","author":"O Makitie","year":"2013","unstructured":"Makitie O (2013) Causes, mechanisms and management of paediatric osteoporosis. Nat Rev Rheumatol 9:465\u2013475","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"3515_CR3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00431-014-2454-8","volume":"174","author":"V Saraff","year":"2015","unstructured":"Saraff V, Schneider J, Colleselli V, Ruepp M, Rauchenzauner M, Neururer S, Geiger R, Hogler W (2015) Sex-, age-, and height-specific reference curves for the 6-min walk test in healthy children and adolescents. Eur J Pediatr 174(6):837\u2013840","journal-title":"Eur J Pediatr"},{"key":"3515_CR4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jocd.2014.01.005","volume":"17","author":"ML Bianchi","year":"2014","unstructured":"Bianchi ML, Leonard MB, Bechtold S, Hogler W, Mughal MZ, Schonau E, Sylvester FA, Vogiatzi M, van den Heuvel-Eibrink MM, Ward L (2014) Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions. J Clin Densitom 17:281\u2013294","journal-title":"J Clin Densitom"},{"key":"3515_CR5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377\u20131385","journal-title":"Lancet"},{"key":"3515_CR6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jbmr.1942","volume":"28","author":"IM Ben Amor","year":"2013","unstructured":"Ben Amor IM, Roughley P, Glorieux FH, Rauch F (2013) Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1. J Bone Miner Res 28:2001\u20132007","journal-title":"J Bone Miner Res"},{"key":"3515_CR7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MOP.0000000000000117","volume":"26","author":"JC Marini","year":"2014","unstructured":"Marini JC, Reich A, Smith SM (2014) Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr 26:500\u2013507","journal-title":"Curr Opin Pediatr"},{"key":"3515_CR8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ejhg.2009.242","volume":"18","author":"F Rauch","year":"2010","unstructured":"Rauch F, Lalic L, Roughley P, Glorieux FH (2010) Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. Eur J Hum Genet 18:642\u2013647","journal-title":"Eur J Hum Genet"},{"key":"3515_CR9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/j.seminhematol.2013.06.007","volume":"50","author":"CH Pui","year":"2013","unstructured":"Pui CH, Evans WE (2013) A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol 50:185\u2013196","journal-title":"Semin Hematol"},{"key":"3515_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77\u201393","journal-title":"Lancet Neurol"},{"key":"3515_CR11","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1210\/JC.2015-2176","volume":"100","author":"EA Cummings","year":"2015","unstructured":"Cummings EA, Ma J, Fernandez CV, Halton J, Alos N, Miettunen PM, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lang B, Israels S, Grant RM, Couch R, Barr R, Hay J, Rauch F, Siminoski K, Ward LM (2015) Incident vertebral fractures in children with leukemia during the four years following diagnosis. J Clin Endocrinol Metab 100:3408\u20133417","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR12","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/jbmr.2511","volume":"30","author":"CM LeBlanc","year":"2015","unstructured":"LeBlanc CM, Ma J, Taljaard M, Roth J, Scuccimarri R, Miettunen P, Lang B, Huber AM, Houghton K, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stein R, Sbrocchi AM, Oen K, Rodd C, Jurencak R, Cummings EA, Couch R, Cabral DA, Atkinson S, Alos N, Rauch F, Siminoski K, Ward LM (2015) Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders. J Bone Miner Res 30:1667\u20131675","journal-title":"J Bone Miner Res"},{"key":"3515_CR13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S0317167100009926","volume":"37","author":"HJ McMillan","year":"2010","unstructured":"McMillan HJ, Campbell C, Mah JK (2010) Duchenne muscular dystrophy: Canadian paediatric neuromuscular physicians survey. Can J Neurol Sci 37:195\u2013205","journal-title":"Can J Neurol Sci"},{"key":"3515_CR14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1586\/1744666X.2014.955017","volume":"10","author":"JS Hyams","year":"2014","unstructured":"Hyams JS (2014) Biologics in pediatric Crohn\u2019s disease: is it time to move to an earlier therapeutic approach? Expert Rev Clin Immunol 10:1423\u20131426","journal-title":"Expert Rev Clin Immunol"},{"key":"3515_CR15","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cgh.2008.07.010","volume":"6","author":"M Thayu","year":"2008","unstructured":"Thayu M, Leonard MB, Hyams JS, Crandall WV, Kugathasan S, Otley AR, Olson A, Johanns J, Marano CW, Heuschkel RB, Veereman-Wauters G, Griffiths AM, Baldassano RN (2008) Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn\u2019s disease: results of the REACH study. Clin Gastroenterol Hepatol 6:1378\u20131384","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3515_CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.berh.2014.03.005","volume":"28","author":"EA Kessler","year":"2014","unstructured":"Kessler EA, Becker ML (2014) Therapeutic advancements in juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 28:293\u2013313","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3515_CR17","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/rheumatology\/keq123","volume":"49","author":"AD Billiau","year":"2010","unstructured":"Billiau AD, Loop M, Le PQ, Berthet F, Philippet P, Kasran A, Wouters CH (2010) Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis. Rheumatology (Oxford) 49:1550\u20131558","journal-title":"Rheumatology (Oxford)"},{"key":"3515_CR18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/rheumatology\/keh592","volume":"44","author":"G Simonini","year":"2005","unstructured":"Simonini G, Giani T, Stagi S, de Martino M, Falcini F (2005) Bone status over 1\u00a0yr of etanercept treatment in juvenile idiopathic arthritis. Rheumatology (Oxford) 44:777\u2013780","journal-title":"Rheumatology (Oxford)"},{"key":"3515_CR19","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1210\/jc.2014-4152","volume":"100","author":"LM Griffin","year":"2015","unstructured":"Griffin LM, Thayu M, Baldassano RN, DeBoer MD, Zemel BS, Denburg MR, Denson LA, Shults J, Herskovitz R, Long J, Leonard MB (2015) Improvements in bone density and structure during anti-TNF-alpha therapy in pediatric Crohn\u2019s disease. J Clin Endocrinol Metab 100:2630\u20132639","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR20","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319\u20131328","journal-title":"Osteoporos Int"},{"key":"3515_CR21","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","volume":"68","author":"WM King","year":"2007","unstructured":"King WM, Ruttencutter R, Nagaraja HN, Matkovic V, Landoll J, Hoyle C, Mendell JR, Kissel JT (2007) Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 68:1607\u20131613","journal-title":"Neurology"},{"key":"3515_CR22","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1359\/jbmr.090202","volume":"24","author":"J Halton","year":"2009","unstructured":"Halton J, Gaboury I, Grant R, Alos N, Cummings EA, Matzinger M, Shenouda N, Lentle B, Abish S, Atkinson S, Cairney E, Dix D, Israels S, Stephure D, Wilson B, Hay J, Moher D, Rauch F, Siminoski K, Ward LM, Canadian STOPP Consortium (2009) Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 24:1326\u20131334","journal-title":"J Bone Miner Res"},{"key":"3515_CR23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00198-011-1621-2","volume":"23","author":"J Feber","year":"2012","unstructured":"Feber J, Gaboury I, Ni A, Alos N, Arora S, Bell L, Blydt-Hansen T, Clarson C, Filler G, Hay J, Hebert D, Lentle B, Matzinger M, Midgley J, Moher D, Pinsk M, Rauch F, Rodd C, Shenouda N, Siminoski K, Ward LM (2012) Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int 23:751\u2013760","journal-title":"Osteoporos Int"},{"key":"3515_CR24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/acr.20171","volume":"62","author":"AM Huber","year":"2010","unstructured":"Huber AM, Gaboury I, Cabral DA, Lang B, Ni A, Stephure D, Taback S, Dent P, Ellsworth J, LeBlanc C, Saint-Cyr C, Scuccimarri R, Hay J, Lentle B, Matzinger M, Shenouda N, Moher D, Rauch F, Siminoski K, Ward LM (2010) Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) 62:516\u2013526","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3515_CR25","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1200\/JCO.2011.40.4830","volume":"30","author":"N Alos","year":"2012","unstructured":"Alos N, Grant RM, Ramsay T, Halton J, Cummings EA, Miettunen PM, Abish S, Atkinson S, Barr R, Cabral DA, Cairney E, Couch R, Dix DB, Fernandez CV, Hay J, Israels S, Laverdiere C, Lentle B, Lewis V, Matzinger M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Wilson B, Williams K, Rauch F, Siminoski K, Ward LM (2012) High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12\u00a0months after the initiation of therapy. J Clin Oncol 30:2760\u20132767","journal-title":"J Clin Oncol"},{"key":"3515_CR26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00198-013-2466-7","volume":"25","author":"V Phan","year":"2014","unstructured":"Phan V, Blydt-Hansen T, Feber J, Alos N, Arora S, Atkinson S, Bell L, Clarson C, Couch R, Cummings EA, Filler G, Grant RM, Grimmer J, Hebert D, Lentle B, Ma J, Matzinger M, Midgley J, Pinsk M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Williams K, Rauch F, Siminoski K, Ward LM (2014) Skeletal findings in the first 12\u00a0months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome. Osteoporos Int 25:627\u2013637","journal-title":"Osteoporos Int"},{"key":"3515_CR27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/acr.20589","volume":"64","author":"C Rodd","year":"2012","unstructured":"Rodd C, Lang B, Ramsay T, Alos N, Huber AM, Cabral DA, Scuccimarri R, Miettunen PM, Roth J, Atkinson SA, Couch R, Cummings EA, Dent PB, Ellsworth J, Hay J, Houghton K, Jurencak R, Larche M, LeBlanc C, Oen K, Saint-Cyr C, Stein R, Stephure D, Taback S, Lentle B, Matzinger M, Shenouda N, Moher D, Rauch F, Siminoski K, Ward LM (2012) Incident vertebral fractures among children with rheumatic disorders 12\u00a0months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken) 64:122\u2013131","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3515_CR28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1469-8749.2009.03464.x","volume":"52","author":"P Kilpinen-Loisa","year":"2010","unstructured":"Kilpinen-Loisa P, Paasio T, Soiva M, Ritanen UM, Lautala P, Palmu P, Pihko H, Makitie O (2010) Low bone mass in patients with motor disability: prevalence and risk factors in 59 Finnish children. Dev Med Child Neurol 52:276\u2013282","journal-title":"Dev Med Child Neurol"},{"key":"3515_CR29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","volume":"17","author":"N Bishop","year":"2014","unstructured":"Bishop N, Arundel P, Clark E, Dimitri P, Farr J, Jones G, Makitie O, Munns CF, Shaw N (2014) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 pediatric official positions. J Clin Densitom 17:275\u2013280","journal-title":"J Clin Densitom"},{"key":"3515_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pbc.20701","volume":"48","author":"W Hogler","year":"2007","unstructured":"Hogler W, Wehl G, van Staa T, Meister B, Klein-Franke A, Kropshofer G (2007) Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Pediatr Blood Cancer 48:21\u201327","journal-title":"Pediatr Blood Cancer"},{"key":"3515_CR31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","volume":"18","author":"TP Staa van","year":"2003","unstructured":"van Staa TP, Cooper C, Leufkens HG, Bishop N (2003) Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 18:913\u2013918","journal-title":"J Bone Miner Res"},{"key":"3515_CR32","first-page":"310","volume":"34","author":"JM Baty","year":"1935","unstructured":"Baty JM, Vogt EC (1935) Bone changes of leukemia in children. Am J Roentgenol 34:310\u2013313","journal-title":"Am J Roentgenol"},{"key":"3515_CR33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1359\/JBMR.051107","volume":"21","author":"I Helenius","year":"2006","unstructured":"Helenius I, Remes V, Salminen S, Valta H, Makitie O, Holmberg C, Palmu P, Tervahartiala P, Sarna S, Helenius M, Peltonen J, Jalanko H (2006) Incidence and predictors of fractures in children after solid organ transplantation: a 5-year prospective, population-based study. J Bone Miner Res 21:380\u2013387","journal-title":"J Bone Miner Res"},{"key":"3515_CR34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-6143.2007.02015.x","volume":"8","author":"H Valta","year":"2008","unstructured":"Valta H, Jalanko H, Holmberg C, Helenius I, Makitie O (2008) Impaired bone health in adolescents after liver transplantation. Am J Transplant 8:150\u2013157","journal-title":"Am J Transplant"},{"key":"3515_CR35","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1359\/jbmr.090407","volume":"24","author":"H Valta","year":"2009","unstructured":"Valta H, Makitie O, Ronnholm K, Jalanko H (2009) Bone health in children and adolescents after renal transplantation. J Bone Miner Res 24:1699\u20131708","journal-title":"J Bone Miner Res"},{"key":"3515_CR36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00198-003-1532-y","volume":"15","author":"LM Vautour","year":"2004","unstructured":"Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT (2004) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 15:160\u2013167","journal-title":"Osteoporos Int"},{"key":"3515_CR37","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.091007","volume":"25","author":"RC Henderson","year":"2010","unstructured":"Henderson RC, Berglund LM, May R, Zemel BS, Grossberg RI, Johnson J, Plotkin H, Stevenson RD, Szalay E, Wong B, Kecskemethy HH, Harcke HT (2010) The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy. J Bone Miner Res 25:520\u2013526","journal-title":"J Bone Miner Res"},{"key":"3515_CR38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jbmr.5650090704","volume":"9","author":"DA Nelson","year":"1994","unstructured":"Nelson DA, Kleerekoper M, Peterson EL (1994) Reversal of vertebral deformities in osteoporosis: measurement error or \u201crebound\u201d? J Bone Miner Res 9:977\u2013982","journal-title":"J Bone Miner Res"},{"key":"3515_CR39","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s00198-012-1911-3","volume":"23","author":"AM Sbrocchi","year":"2012","unstructured":"Sbrocchi AM, Rauch F, Jacob P, McCormick A, McMillan HJ, Matzinger MA, Ward LM (2012) The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy. Osteoporos Int 23:2703\u20132711","journal-title":"Osteoporos Int"},{"key":"3515_CR40","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2012-2393","volume":"97","author":"S Mostoufi-Moab","year":"2012","unstructured":"Mostoufi-Moab S, Brodsky J, Isaacoff EJ, Tsampalieros A, Ginsberg JP, Zemel B, Shults J, Leonard MB (2012) Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation. J Clin Endocrinol Metab 97:3584\u20133592","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR41","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1542\/peds.2004-1838","volume":"116","author":"D Marinovic","year":"2005","unstructured":"Marinovic D, Dorgeret S, Lescoeur B, Alberti C, Noel M, Czernichow P, Sebag G, Vilmer E, Leger J (2005) Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study. Pediatrics 116:e102\u2013e108","journal-title":"Pediatrics"},{"key":"3515_CR42","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/pbc.25010","volume":"61","author":"JG Gurney","year":"2014","unstructured":"Gurney JG, Kaste SC, Liu W, Srivastava DK, Chemaitilly W, Ness KK, Lanctot JQ, Ojha RP, Nottage KA, Wilson CL, Li Z, Robison LL, Hudson MM (2014) Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 61:1270\u20131276","journal-title":"Pediatr Blood Cancer"},{"key":"3515_CR43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/EJE-12-0702","volume":"168","author":"O Makitie","year":"2013","unstructured":"Makitie O, Heikkinen R, Toiviainen-Salo S, Henriksson M, Puukko-Viertomies LR, Jahnukainen K (2013) Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study. Eur J Endocrinol 168:281\u2013288","journal-title":"Eur J Endocrinol"},{"key":"3515_CR44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1359\/jbmr.1997.12.1.152","volume":"12","author":"H Burger","year":"1997","unstructured":"Burger H, Van Daele PL, Grashuis K, Hofman A, Grobbee DE, Schutte HE, Birkenhager JC, Pols HA (1997) Vertebral deformities and functional impairment in men and women. J Bone Miner Res 12:152\u2013157","journal-title":"J Bone Miner Res"},{"key":"3515_CR45","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-128-10-199805150-00001","volume":"128","author":"MC Nevitt","year":"1998","unstructured":"Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, Segal M, Genant HK, Cummings SR (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128:793\u2013800","journal-title":"Ann Intern Med"},{"key":"3515_CR46","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00198-008-0832-7","volume":"20","author":"S Kerkeni","year":"2009","unstructured":"Kerkeni S, Kolta S, Fechtenbaum J, Roux C (2009) Spinal deformity index (SDI) is a good predictor of incident vertebral fractures. Osteoporos Int 20:1547\u20131552","journal-title":"Osteoporos Int"},{"key":"3515_CR47","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1210\/jc.2010-0677","volume":"95","author":"J Kocks","year":"2010","unstructured":"Kocks J, Ward K, Mughal Z, Moncayo R, Adams J, Hogler W (2010) Z-score comparability of bone mineral density reference databases for children. J Clin Endocrinol Metab 95:4652\u20134659","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0022-3476(99)70020-X","volume":"135","author":"MB Leonard","year":"1999","unstructured":"Leonard MB, Propert KJ, Zemel BS, Stallings VA, Feldman HI (1999) Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr 135:182\u2013188","journal-title":"J Pediatr"},{"key":"3515_CR49","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1210\/jc.2014-3096","volume":"100","author":"J Ma","year":"2015","unstructured":"Ma J, Siminoski K, Alos N, Halton J, Ho J, Lentle B, Matzinger M, Shenouda N, Atkinson S, Barr R, Cabral DA, Couch R, Cummings EA, Fernandez CV, Grant RM, Rodd C, Sbrocchi AM, Scharke M, Rauch F, Ward LM (2015) The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures. J Clin Endocrinol Metab 100:1018\u20131027","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR50","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"3515_CR51","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1007\/s00586-003-0613-0","volume":"12","author":"M Grigoryan","year":"2003","unstructured":"Grigoryan M, Guermazi A, Roemer FW, Delmas PD, Genant HK (2003) Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J 12(Suppl 2):S104\u2013S112","journal-title":"Eur Spine J"},{"key":"3515_CR52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jbmr.5650060302","volume":"6","author":"R Eastell","year":"1991","unstructured":"Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton LJ 3rd (1991) Classification of vertebral fractures. J Bone Miner Res 6:207\u2013215","journal-title":"J Bone Miner Res"},{"issue":"12","key":"3515_CR53","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/jbmr.2567","volume":"30","author":"T Palomo","year":"2015","unstructured":"Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, Rauch F (2015) Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years. J Bone Miner Res 30(12):2150\u20132157","journal-title":"J Bone Miner Res"},{"key":"3515_CR54","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.5650110716","volume":"11","author":"HK Genant","year":"1996","unstructured":"Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:984\u2013996","journal-title":"J Bone Miner Res"},{"key":"3515_CR55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00247-013-2837-4","volume":"44","author":"K Siminoski","year":"2014","unstructured":"Siminoski K, Lentle B, Matzinger MA, Shenouda N, Ward LM (2014) Observer agreement in pediatric semiquantitative vertebral fracture diagnosis. Pediatr Radiol 44:457\u2013466","journal-title":"Pediatr Radiol"},{"key":"3515_CR56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0049-0172(00)80011-6","volume":"29","author":"JD Adachi","year":"2000","unstructured":"Adachi JD, Olszynski WP, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, Brown J, Cowden EA, Goltzman D, Ioannidis G, Josse RG, Ste-Marie LG, Tenenhouse AM, Davison KS, Blocka KL, Pollock AP, Sibley J (2000) Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum 29:228\u2013251","journal-title":"Semin Arthritis Rheum"},{"key":"3515_CR57","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00198-007-0381-5","volume":"18","author":"N Vallarta-Ast","year":"2007","unstructured":"Vallarta-Ast N, Krueger D, Wrase C, Agrawal S, Binkley N (2007) An evaluation of densitometric vertebral fracture assessment in men. Osteoporos Int 18:1405\u20131410","journal-title":"Osteoporos Int"},{"key":"3515_CR58","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C","volume":"43","author":"LR Spiegel","year":"2000","unstructured":"Spiegel LR, Schneider R, Lang BA, Birdi N, Silverman ED, Laxer RM, Stephens D, Feldman BM (2000) Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum 43:2402\u20132409","journal-title":"Arthritis Rheum"},{"key":"3515_CR59","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00198-011-1837-1","volume":"23","author":"K Siminoski","year":"2012","unstructured":"Siminoski K, Lee KC, Jen H, Warshawski R, Matzinger MA, Shenouda N, Charron M, Coblentz C, Dubois J, Kloiber R, Nadel H, O\u2019Brien K, Reed M, Sparrow K, Webber C, Lentle B, Ward LM (2012) Anatomical distribution of vertebral fractures: comparison of pediatric and adult spines. Osteoporos Int 23:1999\u20132008","journal-title":"Osteoporos Int"},{"key":"3515_CR60","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00198-009-0972-4","volume":"21","author":"B Buehring","year":"2010","unstructured":"Buehring B, Krueger D, Checovich M, Gemar D, Vallarta-Ast N, Genant HK, Binkley N (2010) Vertebral fracture assessment: impact of instrument and reader. Osteoporos Int 21:487\u2013494","journal-title":"Osteoporos Int"},{"key":"3515_CR61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bone.2007.05.012","volume":"41","author":"MK Mayranpaa","year":"2007","unstructured":"Mayranpaa MK, Helenius I, Valta H, Mayranpaa MI, Toiviainen-Salo S, Makitie O (2007) Bone densitometry in the diagnosis of vertebral fractures in children: accuracy of vertebral fracture assessment. Bone 41:353\u2013359","journal-title":"Bone"},{"key":"3515_CR62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S8756-3282(99)00257-4","volume":"26","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, Parfitt AM (2000) Normative data for iliac bone histomorphometry in growing children. Bone 26:103\u2013109","journal-title":"Bone"},{"key":"3515_CR63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1546-0096-11-6","volume":"11","author":"J Bacchetta","year":"2013","unstructured":"Bacchetta J, Wesseling-Perry K, Gilsanz V, Gales B, Pereira RC, Salusky IB (2013) Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography. Pediatr Rheumatol Online J 11:6","journal-title":"Pediatr Rheumatol Online J"},{"key":"3515_CR64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000223688","volume":"16","author":"F Rauch","year":"2009","unstructured":"Rauch F (2009) Bone biopsy: indications and methods. Endocr Dev 16:49\u201357","journal-title":"Endocr Dev"},{"key":"3515_CR65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","volume":"17","author":"NJ Crabtree","year":"2014","unstructured":"Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, Jaworski M, Gordon CM (2014) Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom 17:225\u2013242","journal-title":"J Clin Densitom"},{"key":"3515_CR66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jocd.2009.01.005","volume":"12","author":"BS Zemel","year":"2009","unstructured":"Zemel BS, Stallings VA, Leonard MB, Paulhamus DR, Kecskemethy HH, Harcke HT, Henderson RC (2009) Revised pediatric reference data for the lateral distal femur measured by Hologic Discovery\/Delphi dual-energy X-ray absorptiometry. J Clin Densitom 12:207\u2013218","journal-title":"J Clin Densitom"},{"key":"3515_CR67","volume-title":"Radiographic atlas of skeletal development of the hand and wrist. Second edition","author":"WW Greulich","year":"1959","unstructured":"Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist. Second edition. Stanford University Press, Stanford"},{"key":"3515_CR68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0169-6009(92)90712-M","volume":"17","author":"H Kroger","year":"1992","unstructured":"Kroger H, Kotaniemi A, Vainio P, Alhava E (1992) Bone densitometry of the spine and femur in children by dual-energy X-ray absorptiometry. Bone Miner 17:75\u201385","journal-title":"Bone Miner"},{"key":"3515_CR69","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","volume":"96","author":"BS Zemel","year":"2011","unstructured":"Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Frederick MM, Huang X, Lu M, Mahboubi S, Hangartner T, Winer KK (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96:3160\u20133169","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR70","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00198-012-2263-8","volume":"24","author":"NJ Crabtree","year":"2013","unstructured":"Crabtree NJ, Hogler W, Cooper MS, Shaw NJ (2013) Diagnostic evaluation of bone densitometric size adjustment techniques in children with and without low trauma fractures. Osteoporos Int 24:2015\u20132024","journal-title":"Osteoporos Int"},{"key":"3515_CR71","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jpeds.2005.07.014","volume":"147","author":"T Binkley","year":"2005","unstructured":"Binkley T, Johnson J, Vogel L, Kecskemethy H, Henderson R, Specker B (2005) Bone measurements by peripheral quantitative computed tomography (pQCT) in children with cerebral palsy. J Pediatr 147:791\u2013796","journal-title":"J Pediatr"},{"key":"3515_CR72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2265.2009.03686.x","volume":"72","author":"W Hogler","year":"2010","unstructured":"Hogler W, Shaw N (2010) Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clin Endocrinol (Oxf) 72:281\u2013289","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3515_CR73","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1515\/CCLM.2011.602","volume":"49","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Cooper C, Eastell R, Griesmacher A, Morris HA, Trenti T, Kanis JA (2011) International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med 49:1271\u20131274","journal-title":"Clin Chem Lab Med"},{"key":"3515_CR74","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/jc.2006-1706","volume":"92","author":"M Rauchenzauner","year":"2007","unstructured":"Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Hogler W (2007) Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2\u00a0months to 18\u00a0years. J Clin Endocrinol Metab 92:443\u2013449","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR75","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00198-013-2485-4","volume":"25","author":"M Bayer","year":"2014","unstructured":"Bayer M (2014) Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0\u201318\u00a0years. Osteoporos Int 25:729\u2013736","journal-title":"Osteoporos Int"},{"key":"3515_CR76","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1515\/cclm-2012-0531","volume":"51","author":"A Morovat","year":"2013","unstructured":"Morovat A, Catchpole A, Meurisse A, Carlisi A, Bekaert AC, Rousselle O, Paddon M, James T, Cavalier E (2013) IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clin Chem Lab Med 51:2009\u20132018","journal-title":"Clin Chem Lab Med"},{"key":"3515_CR77","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.clinbiochem.2011.04.008","volume":"44","author":"Y Huang","year":"2011","unstructured":"Huang Y, Eapen E, Steele S, Grey V (2011) Establishment of reference intervals for bone markers in children and adolescents. Clin Biochem 44:771\u2013778","journal-title":"Clin Biochem"},{"key":"3515_CR78","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MED.0b013e3283591492","volume":"19","author":"E Biver","year":"2012","unstructured":"Biver E (2012) Use of bone turnover markers in clinical practice. Curr Opin Endocrinol Diabetes Obes 19:468\u2013473","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"3515_CR79","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jocd.2011.05.008","volume":"14","author":"EV McCloskey","year":"2011","unstructured":"McCloskey EV, Vasikaran S, Cooper C (2011) Official Positions for FRAX(R) clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R). J Clin Densitom 14:220\u2013222","journal-title":"J Clin Densitom"},{"key":"3515_CR80","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","volume":"18","author":"R Eastell","year":"2003","unstructured":"Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD (2003) Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 18:1051\u20131056","journal-title":"J Bone Miner Res"},{"key":"3515_CR81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1359\/JBMR.0301231","volume":"19","author":"MJ Seibel","year":"2004","unstructured":"Seibel MJ, Naganathan V, Barton I, Grauer A (2004) Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. J Bone Miner Res 19:323\u2013329","journal-title":"J Bone Miner Res"},{"key":"3515_CR82","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bone.2006.02.003","volume":"39","author":"PD Delmas","year":"2006","unstructured":"Delmas PD, Licata AA, Reginster JY, Crans GG, Chen P, Misurski DA, Wagman RB, Mitlak BH (2006) Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover. Bone 39:237\u2013243","journal-title":"Bone"},{"key":"3515_CR83","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1359\/jbmr.07090b","volume":"22","author":"R Eastell","year":"2007","unstructured":"Eastell R, Hannon RA, Garnero P, Campbell MJ, Delmas PD (2007) Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis. J Bone Miner Res 22:1656\u20131660","journal-title":"J Bone Miner Res"},{"key":"3515_CR84","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jc.2002-021371","volume":"88","author":"F Rauch","year":"2003","unstructured":"Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH (2003) Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab 88:986\u2013992","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR85","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","volume":"110","author":"F Rauch","year":"2002","unstructured":"Rauch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 110:1293\u20131299","journal-title":"J Clin Invest"},{"key":"3515_CR86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00198-009-0969-z","volume":"21","author":"LM Ward","year":"2010","unstructured":"Ward LM, Rauch F, Matzinger MA, Benchimol EI, Boland M, Mack DR (2010) Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease. Osteoporos Int 21:331\u2013337","journal-title":"Osteoporos Int"},{"key":"3515_CR87","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1359\/JBMR.050101","volume":"20","author":"H Hartikka","year":"2005","unstructured":"Hartikka H, Makitie O, Mannikko M, Doria AS, Daneman A, Cole WG, Ala-Kokko L, Sochett EB (2005) Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 20:783\u2013789","journal-title":"J Bone Miner Res"},{"key":"3515_CR88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bone.2013.07.020","volume":"57","author":"S Fahiminiya","year":"2013","unstructured":"Fahiminiya S, Majewski J, Roughley P, Roschger P, Klaushofer K, Rauch F (2013) Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density. Bone 57:41\u201346","journal-title":"Bone"},{"key":"3515_CR89","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML, Hamdan MA, Bishop N, Lutz RE, McGinn M, Craig S, Moore JN, Taylor JW, Cleveland RH, Cranley WR, Lim R, Thacher TD, Mayhew JE, Downs M, Millan JL, Skrinar AM, Crine P, Landy H (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. New Eng J Med 366:904\u2013913","journal-title":"New Eng J Med"},{"key":"3515_CR90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpeds.2006.03.013","volume":"149","author":"F Antoniazzi","year":"2006","unstructured":"Antoniazzi F, Zamboni G, Lauriola S, Donadi L, Adami S, Tato L (2006) Early bisphosphonate treatment in infants with severe osteogenesis imperfecta. J Pediatr 149:174\u2013179","journal-title":"J Pediatr"},{"key":"3515_CR91","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","volume":"363","author":"R Sakkers","year":"2004","unstructured":"Sakkers R, Kok D, Engelbert R, van Dongen A, Jansen M, Pruijs H, Verbout A, Schweitzer D, Uiterwaal C (2004) Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study. Lancet 363:1427\u20131431","journal-title":"Lancet"},{"key":"3515_CR92","unstructured":"Ward LM, Glorieux FH, Rauch F, Verbruggen N, Heyden N, Lombardi A (2005) A randomized, placebo-controlled trial of oral alendronate in children and adolescents with osteogenesis imperfecta. Bone 36"},{"key":"3515_CR93","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","volume":"24","author":"F Rauch","year":"2009","unstructured":"Rauch F, Munns CF, Land C, Cheung M, Glorieux FH (2009) Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Bone Miner Res 24:1282\u20131289","journal-title":"J Bone Miner Res"},{"key":"3515_CR94","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S8756-3282(95)00162-X","volume":"17","author":"H Kroger","year":"1995","unstructured":"Kroger H, Vainio P, Nieminen J, Kotaniemi A (1995) Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone 17:157\u2013159","journal-title":"Bone"},{"key":"3515_CR95","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","volume":"7","author":"DR Carter","year":"1992","unstructured":"Carter DR, Bouxsein ML, Marcus R (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137\u2013145","journal-title":"J Bone Miner Res"},{"key":"3515_CR96","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jocd.2007.12.003","volume":"11","author":"F Rauch","year":"2008","unstructured":"Rauch F, Plotkin H, DiMeglio L, Engelbert RH, Henderson RC, Munns C, Wenkert D, Zeitler P (2008) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom 11:22\u201328","journal-title":"J Clin Densitom"},{"key":"3515_CR97","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2013-1505","volume":"98","author":"JC Marini","year":"2013","unstructured":"Marini JC, Blissett AR (2013) New genes in bone development: what\u2019s new in osteogenesis imperfecta. J Clin Endocrinol Metab 98:3095\u20133103","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR98","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(78)90763-8","volume":"1","author":"DO Sillence","year":"1978","unstructured":"Sillence DO, Rimoin DL (1978) Classification of osteogenesis imperfect. Lancet 1:1041\u20131042","journal-title":"Lancet"},{"key":"3515_CR99","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bone.2014.06.041","volume":"67","author":"T Palomo","year":"2014","unstructured":"Palomo T, Al-Jallad H, Moffatt P, Glorieux FH, Lentle B, Roschger P, Klaushofer K, Rauch F (2014) Skeletal characteristics associated with homozygous and heterozygous WNT1 mutations. Bone 67:63\u201370","journal-title":"Bone"},{"key":"3515_CR100","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00198-015-3288-6","volume":"26","author":"PJ Mitchell","year":"2015","unstructured":"Mitchell PJ, Cooper C, Dawson-Hughes B, Gordon CM, Rizzoli R (2015) Life-course approach to nutrition. Osteoporos Int 26:2723\u20132742","journal-title":"Osteoporos Int"},{"key":"3515_CR101","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1007\/s11999-015-4467-7","volume":"473","author":"B Specker","year":"2015","unstructured":"Specker B, Thiex NW, Sudhagoni RG (2015) Does exercise influence pediatric bone? A systematic review. Clin Orthop Relat Res 473:3658\u20133672","journal-title":"Clin Orthop Relat Res"},{"key":"3515_CR102","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2014-2173","volume":"134","author":"NH Golden","year":"2014","unstructured":"Golden NH, Abrams SA (2014) Optimizing bone health in children and adolescents. Pediatrics 134:e1229\u2013e1243","journal-title":"Pediatrics"},{"key":"3515_CR103","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrendo.2012.259","volume":"9","author":"SA Abrams","year":"2013","unstructured":"Abrams SA, Coss-Bu JA, Tiosano D (2013) Vitamin D: effects on childhood health and disease. Nat Rev Endocrinol 9:162\u2013170","journal-title":"Nat Rev Endocrinol"},{"key":"3515_CR104","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/nutrit\/nuu065","volume":"73","author":"C Julian-Almarcegui","year":"2015","unstructured":"Julian-Almarcegui C, Gomez-Cabello A, Huybrechts I, Gonzalez-Aguero A, Kaufman JM, Casajus JA, Vicente-Rodriguez G (2015) Combined effects of interaction between physical activity and nutrition on bone health in children and adolescents: a systematic review. Nutr Rev 73:127\u2013139","journal-title":"Nutr Rev"},{"key":"3515_CR105","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3945\/ajcn.115.108456","volume":"102","author":"MN Handel","year":"2015","unstructured":"Handel MN, Heitmann BL, Abrahamsen B (2015) Nutrient and food intakes in early life and risk of childhood fractures: a systematic review and meta-analysis. Am J Clin Nutr 102:1182\u20131195","journal-title":"Am J Clin Nutr"},{"key":"3515_CR106","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/jbmr.2254","volume":"29","author":"VP Tan","year":"2014","unstructured":"Tan VP, Macdonald HM, Kim S, Nettlefold L, Gabel L, Ashe MC, McKay HA (2014) Influence of physical activity on bone strength in children and adolescents: a systematic review and narrative synthesis. J Bone Miner Res 29:2161\u20132181","journal-title":"J Bone Miner Res"},{"key":"3515_CR107","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"Institute of Medicine","year":"2011","unstructured":"Institute of Medicine (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington"},{"key":"3515_CR108","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.2007-1894","volume":"122","author":"M Misra","year":"2008","unstructured":"Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122:398\u2013417","journal-title":"Pediatrics"},{"key":"3515_CR109","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR110","doi-asserted-by":"crossref","first-page":"c7254","DOI":"10.1136\/bmj.c7254","volume":"342","author":"T Winzenberg","year":"2011","unstructured":"Winzenberg T, Powell S, Shaw KA, Jones G (2011) Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis. BMJ 342:c7254","journal-title":"BMJ"},{"key":"3515_CR111","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1210\/jc.2011-1480","volume":"96","author":"T Edouard","year":"2011","unstructured":"Edouard T, Glorieux FH, Rauch F (2011) Predictors and correlates of vitamin D status in children and adolescents with osteogenesis imperfecta. J Clin Endocrinol Metab 96:3193\u20133198","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR112","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/MPG.0b013e3180dca0cc","volume":"45","author":"EI Benchimol","year":"2007","unstructured":"Benchimol EI, Ward LM, Gallagher JC, Rauch F, Barrowman N, Warren J, Beedle S, Mack DR (2007) Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 45:538\u2013545","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3515_CR113","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/pbc.24882","volume":"61","author":"SC Kaste","year":"2014","unstructured":"Kaste SC, Qi A, Smith K, Surprise H, Lovorn E, Boyett J, Ferry RJ Jr, Relling MV, Shurtleff SA, Pui CH, Carbone L, Hudson MM, Ness KK (2014) Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 61:885\u2013893","journal-title":"Pediatr Blood Cancer"},{"key":"3515_CR114","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","volume":"348","author":"E Theodoratou","year":"2014","unstructured":"Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348:g2035","journal-title":"BMJ"},{"key":"3515_CR115","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","volume":"341","author":"MJ Bolland","year":"2010","unstructured":"Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691","journal-title":"BMJ"},{"key":"3515_CR116","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bmj.38950.561400.55","volume":"333","author":"T Winzenberg","year":"2006","unstructured":"Winzenberg T, Shaw K, Fryer J, Jones G (2006) Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials. BMJ 333:775","journal-title":"BMJ"},{"key":"3515_CR117","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jbmr.2036","volume":"29","author":"M Behringer","year":"2014","unstructured":"Behringer M, Gruetzner S, McCourt M, Mester J (2014) Effects of weight-bearing activities on bone mineral content and density in children and adolescents: a meta-analysis. J Bone Miner Res 29:467\u2013478","journal-title":"J Bone Miner Res"},{"key":"3515_CR118","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/apa.13052","volume":"104","author":"G Dubnov-Raz","year":"2015","unstructured":"Dubnov-Raz G, Azar M, Reuveny R, Katz U, Weintraub M, Constantini NW (2015) Changes in fitness are associated with changes in body composition and bone health in children after cancer. Acta Paediatr 104:1055\u20131061","journal-title":"Acta Paediatr"},{"key":"3515_CR119","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1542\/peds.2009-0292","volume":"125","author":"JP Hough","year":"2010","unstructured":"Hough JP, Boyd RN, Keating JL (2010) Systematic review of interventions for low bone mineral density in children with cerebral palsy. Pediatrics 125:e670\u2013e678","journal-title":"Pediatrics"},{"key":"3515_CR120","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.2004.04.199","volume":"22","author":"K Mandel","year":"2004","unstructured":"Mandel K, Atkinson S, Barr RD, Pencharz P (2004) Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol 22:1215\u20131221","journal-title":"J Clin Oncol"},{"key":"3515_CR121","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1542\/peds.108.5.e89","volume":"108","author":"AG Kalayci","year":"2001","unstructured":"Kalayci AG, Kansu A, Girgin N, Kucuk O, Aras G (2001) Bone mineral density and importance of a gluten-free diet in patients with celiac disease in childhood. Pediatrics 108:E89","journal-title":"Pediatrics"},{"key":"3515_CR122","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MPH.0b013e31817541a8","volume":"30","author":"M Avgeri","year":"2008","unstructured":"Avgeri M, Papadopoulou A, Platokouki H, Douros K, Rammos S, Nicolaidou P, Aronis S (2008) Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy. J Pediatr Hematol Oncol 30:592\u2013597","journal-title":"J Pediatr Hematol Oncol"},{"key":"3515_CR123","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1089\/jwh.2014.5077","volume":"24","author":"W Modesto","year":"2015","unstructured":"Modesto W, Bahamondes MV, Bahamondes L (2015) Prevalence of low bone mass and osteoporosis in long-term users of the injectable contraceptive depot medroxyprogesterone acetate. J Womens Health (Larchmt) 24:636\u2013640","journal-title":"J Womens Health (Larchmt)"},{"key":"3515_CR124","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1587\u20131609","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR125","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/mus.23793","volume":"48","author":"M Bodor","year":"2013","unstructured":"Bodor M, McDonald CM (2013) Why short stature is beneficial in Duchenne muscular dystrophy. Muscle Nerve 48:336\u2013342","journal-title":"Muscle Nerve"},{"key":"3515_CR126","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2008.09.072","volume":"136","author":"SE Dubner","year":"2009","unstructured":"Dubner SE, Shults J, Baldassano RN, Zemel BS, Thayu M, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn\u2019s disease. Gastroenterology 136:123\u2013130","journal-title":"Gastroenterology"},{"key":"3515_CR127","first-page":"CD005088","volume":"7","author":"K Dwan","year":"2014","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D (2014) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 7:CD005088","journal-title":"Cochrane Database Syst Rev"},{"key":"3515_CR128","doi-asserted-by":"crossref","unstructured":"Ward L, Tricco AC, Phuong P, Cranney A, Barrowman N, Gaboury I, Rauch F, Tugwell P, Moher D (2007) Bisphosphonate therapy for children and adolescents with secondary osteoporosis. Cochrane Database Syst Rev: CD005324","DOI":"10.1002\/14651858.CD005324.pub2"},{"key":"3515_CR129","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(13)61531-7","volume":"282","author":"LM Ward","year":"2013","unstructured":"Ward LM, Rauch F (2013) Oral bisphosphonates for paediatric osteogenesis imperfecta? Lancet 282:1388\u20131389","journal-title":"Lancet"},{"key":"3515_CR130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. New Eng J Med 339:947\u2013952","journal-title":"New Eng J Med"},{"key":"3515_CR131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/jpem-2012-0016","volume":"25","author":"ER Barros","year":"2012","unstructured":"Barros ER, Saraiva GL, de Oliveira TP, Lazaretti-Castro M (2012) Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab 25:485\u2013491","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3515_CR132","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.103","volume":"25","author":"A Grey","year":"2010","unstructured":"Grey A, Bolland M, Wattie D, Horne A, Gamble G, Reid IR (2010) Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res 25:2251\u20132255","journal-title":"J Bone Miner Res"},{"key":"3515_CR133","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1210\/jc.2004-2054","volume":"90","author":"LM Ward","year":"2005","unstructured":"Ward LM, Denker AE, Porras A, Shugarts S, Kline W, Travers R, Mao C, Rauch F, Maes A, Larson P, Deutsch P, Glorieux FH (2005) Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I. J Clin Endocrinol Metab 90:4051\u20134056","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR134","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/jc.2004-1659","volume":"90","author":"NH Golden","year":"2005","unstructured":"Golden NH, Iglesias EA, Jacobson MS, Carey D, Meyer W, Schebendach J, Hertz S, Shenker IR (2005) Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90:3179\u20133185","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR135","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","volume":"382","author":"N Bishop","year":"2013","unstructured":"Bishop N, Adami S, Ahmed SF, Anton J, Arundel P, Burren CP, Devogelaer JP, Hangartner T, Hosszu E, Lane JM, Lorenc R, Makitie O, Munns CF, Paredes A, Pavlov H, Plotkin H, Raggio CL, Reyes ML, Schoenau E, Semler O, Sillence DO, Steiner RD (2013) Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. Lancet 382:1424\u20131432","journal-title":"Lancet"},{"key":"3515_CR136","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-2600(13)70064-X","volume":"1","author":"ML Bianchi","year":"2013","unstructured":"Bianchi ML, Colombo C, Assael BM, Dubini A, Lombardo M, Quattrucci S, Bella S, Collura M, Messore B, Raia V, Poli F, Bini R, Albanese CV, De Rose V, Costantini D, Romano G, Pustorino E, Magazzu G, Bertasi S, Lucidi V, Traverso G, Coruzzo A, Grzejdziak AD (2013) Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate. Lancet Respir Med 1:377\u2013385","journal-title":"Lancet Respir Med"},{"key":"3515_CR137","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/rheumatology\/keh538","volume":"44","author":"S Rudge","year":"2005","unstructured":"Rudge S, Hailwood S, Horne A, Lucas J, Wu F, Cundy T (2005) Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment. Rheumatology (Oxford) 44:813\u2013818","journal-title":"Rheumatology (Oxford)"},{"key":"3515_CR138","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","volume":"20","author":"D Gatti","year":"2005","unstructured":"Gatti D, Antoniazzi F, Prizzi R, Braga V, Rossini M, Tato L, Viapiana O, Adami S (2005) Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res 20:758\u2013763","journal-title":"J Bone Miner Res"},{"key":"3515_CR139","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.2010-0636","volume":"96","author":"LM Ward","year":"2011","unstructured":"Ward LM, Rauch F, Whyte MP, D\u2019Astous J, Gates PE, Grogan D, Lester EL, McCall RE, Pressly TA, Sanders JO, Smith PA, Steiner RD, Sullivan E, Tyerman G, Smith-Wright DL, Verbruggen N, Heyden N, Lombardi A, Glorieux FH (2011) Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab 96:355\u2013364","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR140","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","volume":"20","author":"CF Munns","year":"2005","unstructured":"Munns CF, Rauch F, Travers R, Glorieux FH (2005) Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J Bone Miner Res 20:1235\u20131243","journal-title":"J Bone Miner Res"},{"key":"3515_CR141","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bone.2006.04.004","volume":"39","author":"C Land","year":"2006","unstructured":"Land C, Rauch F, Munns CF, Sahebjam S, Glorieux FH (2006) Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment. Bone 39:901\u2013906","journal-title":"Bone"},{"key":"3515_CR142","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/adc.2006.096552","volume":"92","author":"E Astrom","year":"2007","unstructured":"Astrom E, Jorulf H, Soderhall S (2007) Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta. Arch Dis Child 92:332\u2013338","journal-title":"Arch Dis Child"},{"key":"3515_CR143","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/jc.2005-2413","volume":"91","author":"F Rauch","year":"2006","unstructured":"Rauch F, Munns C, Land C, Glorieux FH (2006) Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation. J Clin Endocrinol Metab 91:1268\u20131274","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR144","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jpeds.2005.10.041","volume":"148","author":"C Land","year":"2006","unstructured":"Land C, Rauch F, Montpetit K, Ruck-Gibis J, Glorieux FH (2006) Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta. J Pediatr 148:456\u2013460","journal-title":"J Pediatr"},{"key":"3515_CR145","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","volume":"111","author":"L Zeitlin","year":"2003","unstructured":"Zeitlin L, Rauch F, Plotkin H, Glorieux FH (2003) Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 111:1030\u20131036","journal-title":"Pediatrics"},{"key":"3515_CR146","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000323368","volume":"75","author":"I Vuorimies","year":"2011","unstructured":"Vuorimies I, Toiviainen-Salo S, Hero M, Makitie O (2011) Zoledronic acid treatment in children with osteogenesis imperfecta. Horm Res Paediatr 75:346\u2013353","journal-title":"Horm Res Paediatr"},{"key":"3515_CR147","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000354303","volume":"80","author":"HL Ooi","year":"2013","unstructured":"Ooi HL, Briody J, Biggin A, Cowell CT, Munns CF (2013) Intravenous zoledronic acid given every 6\u00a0months in childhood osteoporosis. Horm Res Paediatr 80:179\u2013184","journal-title":"Horm Res Paediatr"},{"key":"3515_CR148","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1515\/JPEM.2003.16.6.887","volume":"16","author":"LM Gandrud","year":"2003","unstructured":"Gandrud LM, Cheung JC, Daniels MW, Bachrach LK (2003) Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis. J Pediatr Endocrinol Metab 16:887\u2013892","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3515_CR149","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1067\/mpd.2003.137","volume":"142","author":"J Steelman","year":"2003","unstructured":"Steelman J, Zeitler P (2003) Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J Pediatr 142:417\u2013423","journal-title":"J Pediatr"},{"key":"3515_CR150","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","volume":"349","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S (2003) Bisphosphonate-induced osteopetrosis. New Eng J Med 349:457\u2013463","journal-title":"New Eng J Med"},{"key":"3515_CR151","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","volume":"40","author":"F Rauch","year":"2007","unstructured":"Rauch F, Cornibert S, Cheung M, Glorieux FH (2007) Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta. Bone 40:821\u2013827","journal-title":"Bone"},{"key":"3515_CR152","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000355111","volume":"81","author":"A Biggin","year":"2014","unstructured":"Biggin A, Briody JN, Ormshaw E, Wong KK, Bennetts BH, Munns CF (2014) Fracture during intravenous bisphosphonate treatment in a child with osteogenesis imperfecta: an argument for a more frequent, low-dose treatment regimen. Horm Res Paediatr 81:204\u2013210","journal-title":"Horm Res Paediatr"},{"key":"3515_CR153","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000369582","volume":"83","author":"A Biggin","year":"2015","unstructured":"Biggin A, Zheng L, Briody JN, Coorey CP, Munns CF (2015) The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta. Horm Res Paediatr 83:183\u2013189","journal-title":"Horm Res Paediatr"},{"key":"3515_CR154","first-page":"324","volume":"60","author":"JP Brown","year":"2014","unstructured":"Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J (2014) Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician 60:324\u2013333","journal-title":"Can Fam Physician"},{"key":"3515_CR155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1515\/jpem-2006-190410","volume":"19","author":"E Unal","year":"2006","unstructured":"Unal E, Abaci A, Bober E, Buyukgebiz A (2006) Efficacy and safety of oral alendronate treatment in children and adolescents with osteoporosis. J Pediatr Endocrinol Metab 19:523\u2013528","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3515_CR156","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"3515_CR157","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0714.2007.00607.x","volume":"37","author":"B Malmgren","year":"2008","unstructured":"Malmgren B, Astrom E, Soderhall S (2008) No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J Oral Pathol Med 37:196\u2013200","journal-title":"J Oral Pathol Med"},{"key":"3515_CR158","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jpeds.2008.05.003","volume":"153","author":"C Chahine","year":"2008","unstructured":"Chahine C, Cheung MS, Head TW, Schwartz S, Glorieux FH, Rauch F (2008) Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J Pediatr 153:719\u2013720","journal-title":"J Pediatr"},{"key":"3515_CR159","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2265.2008.03189.x","volume":"68","author":"JJ Brown","year":"2008","unstructured":"Brown JJ, Ramalingam L, Zacharin MR (2008) Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? Clin Endocrinol (Oxf) 68:863\u2013867","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3515_CR160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/adj.12140","volume":"59","author":"RN Bhatt","year":"2014","unstructured":"Bhatt RN, Hibbert SA, Munns CF (2014) The use of bisphosphonates in children: review of the literature and guidelines for dental management. Aust Dent J 59:9\u201319","journal-title":"Aust Dent J"},{"key":"3515_CR161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O\u2019Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323","journal-title":"J Bone Miner Res"},{"key":"3515_CR162","doi-asserted-by":"publisher","unstructured":"Hegazy A, Kenawey M, Sochett E, Tile L, Cheung AM, Howard AW (2015) Unusual femur stress fractures in children with osteogenesis imperfecta and intramedullary rods on long-term intravenous pamidronate therapy. J Pediatr Orthop Epub ahead of print: 2015 Jun 8 doi: 10.1097\/BPO.0000000000000552","DOI":"10.1097\/BPO.0000000000000552"},{"key":"3515_CR163","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 19:1779\u20131786","journal-title":"J Bone Miner Res"},{"key":"3515_CR164","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/jbmr.2486","volume":"30","author":"EA Anam","year":"2015","unstructured":"Anam EA, Rauch F, Glorieux FH, Fassier F, Hamdy R (2015) Osteotomy healing in children with osteogenesis imperfecta receiving bisphosphonate treatment. J Bone Miner Res 30:1362\u20131368","journal-title":"J Bone Miner Res"},{"key":"3515_CR165","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMc062792","volume":"356","author":"SE Papapoulos","year":"2007","unstructured":"Papapoulos SE, Cremers SC (2007) Prolonged bisphosphonate release after treatment in children. New Eng J Med 356:1075\u20131076","journal-title":"New Eng J Med"},{"key":"3515_CR166","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S1701-2163(16)34026-9","volume":"30","author":"N Djokanovic","year":"2008","unstructured":"Djokanovic N, Klieger-Grossmann C, Koren G (2008) Does treatment with bisphosphonates endanger the human pregnancy? J Obstet Gynaecol Can 30:1146\u20131148","journal-title":"J Obstet Gynaecol Can"},{"key":"3515_CR167","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2146\/ajhp140041","volume":"71","author":"SB Green","year":"2014","unstructured":"Green SB, Pappas AL (2014) Effects of maternal bisphosphonate use on fetal and neonatal outcomes. Am J Health Syst Pharm 71:2029\u20132036","journal-title":"Am J Health Syst Pharm"},{"key":"3515_CR168","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bone.2008.11.001","volume":"44","author":"S Levy","year":"2009","unstructured":"Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D, Moretti M, Koren G, Ito S (2009) Pregnancy outcome following in utero exposure to bisphosphonates. Bone 44:428\u2013430","journal-title":"Bone"},{"key":"3515_CR169","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1359\/JBMR.040711","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Ward L, Glorieux FH (2004) Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases. J Bone Miner Res 19:1742\u20131745","journal-title":"J Bone Miner Res"},{"key":"3515_CR170","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/eat.22248","volume":"47","author":"AT Faje","year":"2014","unstructured":"Faje AT, Fazeli PK, Miller KK, Katzman DK, Ebrahimi S, Lee H, Mendes N, Snelgrove D, Meenaghan E, Misra M, Klibanski A (2014) Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord 47:458\u2013466","journal-title":"Int J Eat Disord"},{"key":"3515_CR171","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jocd.2013.02.011","volume":"17","author":"AD Divasta","year":"2014","unstructured":"Divasta AD, Feldman HA, Gordon CM (2014) Vertebral fracture assessment in adolescents and young women with anorexia nervosa: a case series. J Clin Densitom 17:207\u2013211","journal-title":"J Clin Densitom"},{"key":"3515_CR172","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1530\/JOE-14-0039","volume":"221","author":"M Misra","year":"2014","unstructured":"Misra M, Klibanski A (2014) Anorexia nervosa and bone. J Endocrinol 221:R163\u2013R176","journal-title":"J Endocrinol"},{"key":"3515_CR173","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1249\/mss.0b013e318149f111","volume":"39","author":"A Nattiv","year":"2007","unstructured":"Nattiv A, Loucks AB, Manore MM, Sanborn CF, Sundgot-Borgen J, Warren MP (2007) American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 39:1867\u20131882","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"3515_CR174","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/EJE-14-0865","volume":"173","author":"V Saraff","year":"2015","unstructured":"Saraff V, Hoegler W (2015) Endocrinology and adolescence: osteoporosis in children: diagnosis and management. Eur J Endocrinol 173(6):R185\u2013R1897","journal-title":"Eur J Endocrinol"},{"key":"3515_CR175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000381047","volume":"28","author":"S Korula","year":"2015","unstructured":"Korula S, Titmuss AT, Biggin A, Munns CF (2015) A practical approach to children with recurrent fractures. Endocr Dev 28:210\u2013225","journal-title":"Endocr Dev"},{"issue":"11\u201312","key":"3515_CR176","first-page":"1343","volume":"28","author":"MJ Kim","year":"2015","unstructured":"Kim MJ, Kim SN, Lee IS, Chung S, Lee J, Yang Y, Lee I, Koh SE (2015) Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis. J Pediatr Endocrinol Metab 28(11\u201312):1343\u20131350","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3515_CR177","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","volume":"111","author":"G Eghbali-Fatourechi","year":"2003","unstructured":"Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221\u20131230","journal-title":"J Clin Invest"},{"key":"3515_CR178","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","volume":"24","author":"PJ Kostenuik","year":"2009","unstructured":"Kostenuik PJ, Nguyen HQ, McCabe J, Warmington KS, Kurahara C, Sun N, Chen C, Li L, Cattley RC, Van G, Scully S, Elliott R, Grisanti M, Morony S, Tan HL, Asuncion F, Li X, Ominsky MS, Stolina M, Dwyer D, Dougall WC, Hawkins N, Boyle WJ, Simonet WS, Sullivan JK (2009) Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL. J Bone Miner Res 24:182\u2013195","journal-title":"J Bone Miner Res"},{"key":"3515_CR179","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/art.24445","volume":"60","author":"LC Hofbauer","year":"2009","unstructured":"Hofbauer LC, Zeitz U, Schoppet M, Skalicky M, Schuler C, Stolina M, Kostenuik PJ, Erben RG (2009) Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum 60:1427\u20131437","journal-title":"Arthritis Rheum"},{"key":"3515_CR180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinthera.2012.02.002","volume":"34","author":"DW Dempster","year":"2012","unstructured":"Dempster DW, Lambing CL, Kostenuik PJ, Grauer A (2012) Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. Clin Ther 34:521\u2013536","journal-title":"Clin Ther"},{"key":"3515_CR181","first-page":"183","volume":"12","author":"O Semler","year":"2012","unstructured":"Semler O, Netzer C, Hoyer-Kuhn H, Becker J, Eysel P, Schoenau E (2012) First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI. J Musculoskelet Neuronal Interact 12:183\u2013188","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"3515_CR182","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1200\/JCO.2012.46.4255","volume":"31","author":"NA Karras","year":"2013","unstructured":"Karras NA, Polgreen LE, Ogilvie C, Manivel JC, Skubitz KM, Lipsitz E (2013) Denosumab treatment of metastatic giant-cell tumor of bone in a 10-year-old girl. J Clin Oncol 31:e200\u2013e202","journal-title":"J Clin Oncol"},{"key":"3515_CR183","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00586-013-2715-7","volume":"22","author":"T Lange","year":"2013","unstructured":"Lange T, Stehling C, Frohlich B, Klingenhofer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jurgens H, Schulte TL (2013) Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J 22:1417\u20131422","journal-title":"Eur Spine J"},{"key":"3515_CR184","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","volume":"27","author":"AM Boyce","year":"2012","unstructured":"Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu JZ, Farley FA, Molinolo AA, Bhattacharyya N, Collins MT (2012) Denosumab treatment for fibrous dysplasia. J Bone Miner Res 27:1462\u20131470","journal-title":"J Bone Miner Res"},{"key":"3515_CR185","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1210\/jc.2013-3081","volume":"99","author":"HD Wang","year":"2014","unstructured":"Wang HD, Boyce AM, Tsai JY, Gafni RI, Farley FA, Kasa-Vubu JZ, Molinolo AA, Collins MT (2014) Effects of denosumab treatment and discontinuation on human growth plates. J Clin Endocrinol Metab 99:891\u2013897","journal-title":"J Clin Endocrinol Metab"},{"key":"3515_CR186","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcph.239","volume":"54","author":"D Padhi","year":"2014","unstructured":"Padhi D, Allison M, Kivitz AJ, Gutierrez MJ, Stouch B, Wang C, Jang G (2014) Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study. J Clin Pharmacol 54:168\u2013178","journal-title":"J Clin Pharmacol"},{"key":"3515_CR187","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","volume":"26","author":"D Padhi","year":"2011","unstructured":"Padhi D, Jang G, Stouch B, Fang L, Posvar E (2011) Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 26:19\u201326","journal-title":"J Bone Miner Res"},{"key":"3515_CR188","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/14728214.2014.936377","volume":"19","author":"E Feurer","year":"2014","unstructured":"Feurer E, Chapurlat R (2014) Emerging drugs for osteoporosis. Expert Opin Emerg Drugs 19:385\u2013395","journal-title":"Expert Opin Emerg Drugs"},{"key":"3515_CR189","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/ipd.12176","volume":"25","author":"JA Weintraub","year":"2015","unstructured":"Weintraub JA, Breland CE (2015) Challenges, benefits, and factors to enhance recruitment and inclusion of children in pediatric dental research. Int J Paediatr Dent 25:310\u2013316","journal-title":"Int J Paediatr Dent"},{"key":"3515_CR190","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpeds.2004.10.052","volume":"146","author":"O Makitie","year":"2005","unstructured":"Makitie O, Doria AS, Henriques F, Cole WG, Compeyrot S, Silverman E, Laxer R, Daneman A, Sochett EB (2005) Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr 146:395\u2013401","journal-title":"J Pediatr"},{"key":"3515_CR191","doi-asserted-by":"crossref","unstructured":"Fung EB, Harmatz PR, Milet M, Coates, T, Thompson, AA, Ranalli, M, Mignaca, R Scher, C Giardina, P Robertson, S, Neumayr, L, Vichinsky, E, The Multi-Center Iron Overload Study Group (2008) Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia. Bone 43:162\u2013168","DOI":"10.1016\/j.bone.2008.03.003"},{"key":"3515_CR192","doi-asserted-by":"crossref","unstructured":"Dosa NP, Eckrich M, Katz DA, Turk M, Liptak GS (2007) Incidence, prevalence, and characteristics of fractures in children, adolescents, and adults with spina bifida. J Spinal Cord Med 30 Suppl 1:S5\u20139","DOI":"10.1080\/10790268.2007.11753961"},{"key":"3515_CR193","doi-asserted-by":"crossref","unstructured":"Nakhla M, Scuccimarri R, Duffy KN, Chedeville G, Campillo S, Duffy CM, Azouz EM, Shenouda N, Sharma AK, Rodd C (2009) Prevalence of Vertebral Fractures in Children with Chronic Rheumatic Diseases at Risk for Osteopenia. J Pediatr 154:438\u2013443","DOI":"10.1016\/j.jpeds.2008.09.023"},{"key":"3515_CR194","doi-asserted-by":"crossref","unstructured":"Engkakul P, Mahachoklertwattana P, Jaovisidha S, Chuansumrit A, Poomthavorn P, Chitrapazt N, Chuncharunee S (2013) Unrecognized vertebral fractures in adolescents and young adults with thalassemia syndromes. J Pediatr Hematol Oncol 35:212\u2013217","DOI":"10.1097\/MPH.0b013e3182841574"},{"key":"3515_CR195","doi-asserted-by":"crossref","unstructured":"Mayranpaa MK, Viljakainen HT, Toiviainen-Salo S, Kallio PE, Makitie O (2012) Impaired bone health and asymptomatic vertebral compressions in fracture-prone children: a case-control study. J Bone Miner Res 27:1413\u20131424","DOI":"10.1002\/jbmr.1579"},{"key":"3515_CR196","doi-asserted-by":"crossref","unstructured":"Seikaly MG, Kopanati S, Salhab N, Waber P, Patterson D, Browne R, Herring JA (2005) Impact of alendronate on quality of life in children with osteogenesis imperfecta. J Pediatr Orthop 25:786\u2013791","DOI":"10.1097\/01.bpo.0000176162.78980.ed"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3515-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3515-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3515-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3515-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T02:18:11Z","timestamp":1718504291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3515-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,28]]},"references-count":196,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["3515"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3515-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,28]]}}}